Hisatomi Arima Selected Research

Indapamide

12/2022	Triple Therapy Prevention of Recurrent Intracerebral Disease Events Trial: Rationale, design and progress.
4/2016	Risks associated with permanent discontinuation of blood pressure-lowering medications in patients with type 2 diabetes.
11/2014	Degree of blood pressure reduction and recurrent stroke: the PROGRESS trial.
10/2014	Follow-up of blood-pressure lowering and glucose control in type 2 diabetes.
2/2014	Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the Action In Diabetes and Vascular Disease: Preterax and Diamicron Controlled Evaluation (ADVANCE) trial.
6/2012	Effects of blood pressure lowering on intracranial and extracranial bleeding in patients on antithrombotic therapy: the PROGRESS trial.
8/2011	Effects of blood pressure lowering on major vascular events among patients with isolated diastolic hypertension: the perindopril protection against recurrent stroke study (PROGRESS) trial.
4/2010	Importance of blood pressure lowering in type 2 diabetes: focus on ADVANCE.
2/2010	Effects of perindopril-based lowering of blood pressure on intracerebral hemorrhage related to amyloid angiopathy: the PROGRESS trial.
2/2010	Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hisatomi Arima Research Topics

Disease

59	Stroke (Strokes) 01/2022 - 10/2005
49	Hypertension (High Blood Pressure) 06/2022 - 01/2002
21	Ischemic Stroke 01/2022 - 05/2010
19	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 08/2008
16	Cerebral Hemorrhage 01/2021 - 02/2010
12	Type 2 Diabetes Mellitus (MODY) 04/2022 - 04/2010
12	Atrial Fibrillation 01/2021 - 10/2005
11	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2016 - 10/2005
10	Vascular Diseases (Vascular Disease) 04/2016 - 04/2010
9	Hematoma 01/2019 - 07/2012
8	Chronic Renal Insufficiency 12/2021 - 10/2007
7	Coronary Disease (Coronary Heart Disease) 04/2022 - 07/2008
7	Heart Failure 01/2019 - 06/2009
6	Hypercholesterolemia 01/2021 - 01/2015
6	Diabetes Mellitus 01/2020 - 01/2006
6	Body Weight (Weight, Body) 01/2019 - 12/2015
5	Myocardial Infarction 12/2022 - 01/2016
5	Obesity 07/2021 - 07/2008
5	Atherosclerosis 07/2021 - 06/2003
4	Hemorrhage 01/2022 - 06/2012
4	Neoplasms (Cancer) 01/2021 - 01/2006
4	Infections 01/2021 - 02/2008
4	Proteinuria 01/2019 - 07/2007
3	Cognitive Dysfunction 12/2022 - 01/2011
3	Overweight 04/2022 - 07/2019
3	Frailty 01/2022 - 01/2020
3	Dementia (Dementias) 01/2020 - 09/2018
3	Albuminuria 11/2017 - 11/2012
3	Essential Hypertension 01/2017 - 01/2005
3	Renal Insufficiency (Renal Failure) 01/2016 - 10/2005
3	Insulin Resistance 01/2006 - 09/2002
2	Isolated Systolic Hypertension 12/2022 - 06/2009
2	Pathologic Constriction (Stenosis) 03/2022 - 06/2013
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 06/2017
2	COVID-19 12/2021 - 10/2020
2	Deglutition Disorders (Dysphagia) 12/2020 - 01/2019
2	Colorectal Neoplasms (Colorectal Cancer) 12/2019 - 08/2016
2	Hypotension (Low Blood Pressure) 01/2019 - 01/2019
2	Leiomyoma (Uterine Fibroids) 11/2017 - 07/2017
2	Masked Hypertension 11/2017 - 06/2013
2	White Coat Hypertension 11/2017 - 06/2013
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2017 - 10/2005
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2017 - 06/2014
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2016 - 02/2009
2	Stomach Neoplasms (Stomach Cancer) 08/2016 - 02/2008
2	Dyslipidemias (Dyslipidemia) 01/2015 - 07/2008

Drug/Important Bio-Agent (IBA)

22	Antihypertensive Agents (Antihypertensives)IBA 12/2022 - 08/2008
18	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022 - 07/2015
17	Perindopril FDA LinkGeneric 01/2017 - 10/2005
15	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 09/2002
12	LipidsIBA 07/2018 - 02/2003
11	Indapamide FDA LinkGeneric 12/2022 - 06/2006
9	CreatinineIBA 07/2018 - 01/2002
9	Gliclazide (Diamicron)IBA 04/2016 - 04/2010
9	perindopril drug combination indapamideIBA 04/2016 - 04/2010
8	DiureticsIBA 01/2020 - 06/2006
7	PotassiumIBA 10/2019 - 01/2005
6	Insulin (Novolin)FDA Link 12/2021 - 09/2002
6	AnticoagulantsIBA 01/2021 - 10/2005
6	SodiumIBA 01/2021 - 12/2015
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 06/2011
6	CholesterolIBA 07/2018 - 06/2003
5	Pharmaceutical PreparationsIBA 12/2022 - 06/2009
5	Uric Acid (Urate)IBA 12/2021 - 01/2015
5	Hemoglobins (Hemoglobin)IBA 01/2021 - 02/2008
4	LDL CholesterolIBA 07/2021 - 02/2009
4	Angiotensin Receptor AntagonistsIBA 10/2020 - 01/2018
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2020 - 10/2014
4	HDL CholesterolIBA 01/2018 - 09/2013
4	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2018 - 06/2009
3	salicylhydroxamic acid (SHAM)IBA 01/2022 - 02/2013
3	oxidized low density lipoproteinIBA 07/2021 - 09/2016
3	Warfarin (Coumadin)FDA LinkGeneric 01/2021 - 01/2016
3	AlbuminsIBA 01/2021 - 01/2017
3	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2020 - 06/2006
3	SaltsIBA 01/2019 - 01/2011
3	C-Reactive ProteinIBA 01/2019 - 07/2008
2	Telmisartan (Micardis)FDA Link 12/2022 - 01/2011
2	Amlodipine (Norvasc)FDA LinkGeneric 12/2022 - 01/2018
2	Hypoglycemic Agents (Hypoglycemics)IBA 04/2022 - 09/2013
2	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2002
2	LDL Lipoproteins (beta Lipoproteins)IBA 07/2021 - 09/2016
2	Triglycerides (Triacylglycerol)IBA 01/2021 - 01/2018
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 07/2019 - 10/2014
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2019 - 01/2019
2	cyclo(Arg-Pro) (CI 4)IBA 10/2018 - 02/2010
2	HDL LipoproteinsIBA 01/2018 - 09/2010
2	GelatinIBA 11/2017 - 07/2017
2	trisacryl gelatin microspheresIBA 11/2017 - 07/2017
2	mahuang-tangIBA 11/2017 - 06/2013
2	AldosteroneIBA 06/2016 - 01/2006
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 08/2014 - 06/2014

Therapy/Procedure

37	Therapeutics 12/2022 - 10/2005
7	Secondary Prevention 12/2021 - 08/2006
5	Glycemic Control 07/2019 - 01/2013
5	Contraindications 01/2019 - 06/2006
3	Critical Care (Surgical Intensive Care) 01/2022 - 01/2021
2	Drug Therapy (Chemotherapy) 01/2021 - 12/2019
2	Uterine Artery Embolization 11/2017 - 07/2017
2	Surgical Amputation (Amputations) 01/2017 - 01/2016